1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insomnia Medication Consumption 2016-2026
2.1.2 Insomnia Medication Consumption CAGR by Region
2.2 Insomnia Medication Segment by Type
2.2.1 Nonbenzodiazepine Receptor Agonists
2.2.2 Benzodiazepine Receptor Agonists
2.2.3 The Selective Melatonin Receptor Agonist Ramelteon
2.2.4 Sedating Antidepressants
2.3 Insomnia Medication Sales by Type
2.3.1 Global Insomnia Medication Sales Market Share by Type (2016-2021)
2.3.2 Global Insomnia Medication Revenue and Market Share by Type (2016-2021)
2.3.3 Global Insomnia Medication Sale Price by Type (2016-2021)
2.4 Insomnia Medication Segment by Application
2.4.1 Adults
2.4.2 Kids
2.5 Insomnia Medication Sales by Application
2.5.1 Global Insomnia Medication Sale Market Share by Application (2016-2021)
2.5.2 Global Insomnia Medication Revenue and Market Share by Application (2016-2021)
2.5.3 Global Insomnia Medication Sale Price by Application (2016-2021)
3 Global Insomnia Medication by Company
3.1 Global Insomnia Medication Sales Market Share by Company
3.1.1 Global Insomnia Medication Sales by Company (2019-2021)
3.1.2 Global Insomnia Medication Sales Market Share by Company (2019-2021)
3.2 Global Insomnia Medication Revenue Market Share by Company
3.2.1 Global Insomnia Medication Revenue by Company (2019-2021)
3.2.2 Global Insomnia Medication Revenue Market Share by Company (2019-2021)
3.3 Global Insomnia Medication Sale Price by Company
3.4 Global Manufacturers Insomnia Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insomnia Medication Product Location Distribution
3.4.2 Players Insomnia Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Insomnia Medication by Region
4.1 Global Insomnia Medication by Region
4.1.1 Global Insomnia Medication Sales by Region
4.1.2 Global Insomnia Medication Revenue by Region
4.2 Americas Insomnia Medication Sales Growth
4.3 APAC Insomnia Medication Sales Growth
4.4 Europe Insomnia Medication Sales Growth
4.5 Middle East & Africa Insomnia Medication Sales Growth
5 Americas
5.1 Americas Insomnia Medication Sales by Country
5.1.1 Americas Insomnia Medication Sales by Country (2016-2021)
5.1.2 Americas Insomnia Medication Revenue by Country (2016-2021)
5.2 Americas Insomnia Medication Sales by Type
5.3 Americas Insomnia Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insomnia Medication Sales by Region
6.1.1 APAC Insomnia Medication Sales by Region (2016-2021)
6.1.2 APAC Insomnia Medication Revenue by Region (2016-2021)
6.2 APAC Insomnia Medication Sales by Type
6.3 APAC Insomnia Medication Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Insomnia Medication by Country
7.1.1 Europe Insomnia Medication Sales by Country (2016-2021)
7.1.2 Europe Insomnia Medication Revenue by Country (2016-2021)
7.2 Europe Insomnia Medication Sales by Type
7.3 Europe Insomnia Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insomnia Medication by Country
8.1.1 Middle East & Africa Insomnia Medication Sales by Country (2016-2021)
8.1.2 Middle East & Africa Insomnia Medication Revenue by Country (2016-2021)
8.2 Middle East & Africa Insomnia Medication Sales by Type
8.3 Middle East & Africa Insomnia Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insomnia Medication Distributors
10.3 Insomnia Medication Customer
11 Global Insomnia Medication Market Forecast
11.1 Global Insomnia Medication Forecast by Region
11.1.1 Global Insomnia Medication Forecast by Regions (2021-2026)
11.2.2 Global Insomnia Medication Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Insomnia Medication Forecast by Type
11.7 Global Insomnia Medication Forecast by Application
12 Key Players Analysis
12.1 Eisai
12.1.1 Eisai Eisai Company Information
12.1.2 Eisai Insomnia Medication Product Offered
12.1.3 Eisai Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Eisai Main Business Overview
12.1.5 Eisai Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Insomnia Medication Product Offered
12.2.3 Merck Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Insomnia Medication Product Offered
12.3.3 Pfizer Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Pfizer Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Sanofi
12.4.1 Sanofi Company Information
12.4.2 Sanofi Insomnia Medication Product Offered
12.4.3 Sanofi Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofi Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Takeda
12.5.1 Takeda Company Information
12.5.2 Takeda Insomnia Medication Product Offered
12.5.3 Takeda Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Takeda Main Business Overview
12.5.5 Takeda Latest Developments
12.6 Vanda Pharmaceuticals
12.6.1 Vanda Pharmaceuticals Company Information
12.6.2 Vanda Pharmaceuticals Insomnia Medication Product Offered
12.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Vanda Pharmaceuticals Main Business Overview
12.6.5 Vanda Pharmaceuticals Latest Developments
12.7 Astellas
12.7.1 Astellas Company Information
12.7.2 Astellas Insomnia Medication Product Offered
12.7.3 Astellas Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Astellas Main Business Overview
12.7.5 Astellas Latest Developments
12.8 Dainippon Sumitomo
12.8.1 Dainippon Sumitomo Company Information
12.8.2 Dainippon Sumitomo Insomnia Medication Product Offered
12.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Dainippon Sumitomo Main Business Overview
12.8.5 Dainippon Sumitomo Latest Developments
12.9 ECR Pharmaceuticals (Valeant)
12.9.1 ECR Pharmaceuticals (Valeant) Company Information
12.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offered
12.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 ECR Pharmaceuticals (Valeant) Main Business Overview
12.9.5 ECR Pharmaceuticals (Valeant) Latest Developments
12.10 Flynn Pharma
12.10.1 Flynn Pharma Company Information
12.10.2 Flynn Pharma Insomnia Medication Product Offered
12.10.3 Flynn Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Flynn Pharma Main Business Overview
12.10.5 Flynn Pharma Latest Developments
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Company Information
12.11.2 Johnson & Johnson Insomnia Medication Product Offered
12.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Johnson & Johnson Main Business Overview
12.11.5 Johnson & Johnson Latest Developments
12.12 Meda
12.12.1 Meda Company Information
12.12.2 Meda Insomnia Medication Product Offered
12.12.3 Meda Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Meda Main Business Overview
12.12.5 Meda Latest Developments
12.13 Somnus Therapeutics
12.13.1 Somnus Therapeutics Company Information
12.13.2 Somnus Therapeutics Insomnia Medication Product Offered
12.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Somnus Therapeutics Main Business Overview
12.13.5 Somnus Therapeutics Latest Developments
12.14 Purdue Pharma
12.14.1 Purdue Pharma Company Information
12.14.2 Purdue Pharma Insomnia Medication Product Offered
12.14.3 Purdue Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Purdue Pharma Main Business Overview
12.14.5 Purdue Pharma Latest Developments
12.15 Neurim
12.15.1 Neurim Company Information
12.15.2 Neurim Insomnia Medication Product Offered
12.15.3 Neurim Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Neurim Main Business Overview
12.15.5 Neurim Latest Developments
12.16 Minerva Neurosciences
12.16.1 Minerva Neurosciences Company Information
12.16.2 Minerva Neurosciences Insomnia Medication Product Offered
12.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Minerva Neurosciences Main Business Overview
12.16.5 Minerva Neurosciences Latest Developments
12.17 Pernix Therapeutics
12.17.1 Pernix Therapeutics Company Information
12.17.2 Pernix Therapeutics Insomnia Medication Product Offered
12.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Pernix Therapeutics Main Business Overview
12.17.5 Pernix Therapeutics Latest Developments
12.18 SkyePharma
12.18.1 SkyePharma Company Information
12.18.2 SkyePharma Insomnia Medication Product Offered
12.18.3 SkyePharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 SkyePharma Main Business Overview
12.18.5 SkyePharma Latest Developments
12.19 Paratek Pharmaceuticals
12.19.1 Paratek Pharmaceuticals Company Information
12.19.2 Paratek Pharmaceuticals Insomnia Medication Product Offered
12.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Paratek Pharmaceuticals Main Business Overview
12.19.5 Paratek Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of TablesTable 1. Insomnia Medication Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Nonbenzodiazepine Receptor Agonists
Table 3. Major Players of Benzodiazepine Receptor Agonists
Table 4. Major Players of The Selective Melatonin Receptor Agonist Ramelteon
Table 5. Major Players of Sedating Antidepressants
Table 6. Global Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 7. Global Insomnia Medication Sales Market Share by Type (2016-2021)
Table 8. Global Insomnia Medication Revenue by Type (2016-2021) & ($ million)
Table 9. Global Insomnia Medication Revenue Market Share by Type (2016-2021)
Table 10. Global Insomnia Medication Sale Price by Type (2016-2021)
Table 11. Global Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 12. Global Insomnia Medication Sales Market Share by Application (2016-2021)
Table 13. Global Insomnia Medication Value by Application (2016-2021)
Table 14. Global Insomnia Medication Revenue Market Share by Application (2016-2021)
Table 15. Global Insomnia Medication Sale Price by Application (2016-2021)
Table 16. Global Insomnia Medication Sales by Company (2019-2021) & (K Pcs)
Table 17. Global Insomnia Medication Sales Market Share by Company (2019-2021)
Table 18. Global Insomnia Medication Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Insomnia Medication Revenue Market Share by Company (2019-2021)
Table 20. Global Insomnia Medication Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Insomnia Medication Producing Area Distribution and Sales Area
Table 22. Players Insomnia Medication Products Offered
Table 23. Insomnia Medication Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Insomnia Medication Sales by Region (2016-2021) (K Pcs)
Table 27. Global Insomnia Medication Sales Market Share by Region (2016-2021)
Table 28. Global Insomnia Medication Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Insomnia Medication Revenue Market Share by Region (2016-2021)
Table 30. Americas Insomnia Medication Sales by Country (2016-2021) & (K Pcs)
Table 31. Americas Insomnia Medication Sales Market Share by Country (2016-2021)
Table 32. Americas Insomnia Medication Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Insomnia Medication Revenue Market Share by Country (2016-2021)
Table 34. Americas Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 35. Americas Insomnia Medication Sales Market Share by Type (2016-2021)
Table 36. Americas Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 37. Americas Insomnia Medication Sales Market Share by Application (2016-2021)
Table 38. APAC Insomnia Medication Sales by Region (2016-2021) & (K Pcs)
Table 39. APAC Insomnia Medication Sales Market Share by Region (2016-2021)
Table 40. APAC Insomnia Medication Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Insomnia Medication Revenue Market Share by Region (2016-2021)
Table 42. APAC Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 43. APAC Insomnia Medication Sales Market Share by Type (2016-2021)
Table 44. APAC Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 45. APAC Insomnia Medication Sales Market Share by Application (2016-2021)
Table 46. Europe Insomnia Medication Sales by Country (2016-2021) & (K Pcs)
Table 47. Europe Insomnia Medication Sales Market Share by Country (2016-2021)
Table 48. Europe Insomnia Medication Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Insomnia Medication Revenue Market Share by Country (2016-2021)
Table 50. Europe Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 51. Europe Insomnia Medication Sales Market Share by Type (2016-2021)
Table 52. Europe Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 53. Europe Insomnia Medication Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Insomnia Medication Sales by Country (2016-2021) & (K Pcs)
Table 55. Middle East & Africa Insomnia Medication Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Insomnia Medication Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Insomnia Medication Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 59. Middle East & Africa Insomnia Medication Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 61. Middle East & Africa Insomnia Medication Sales Market Share by Application (2016-2021)
Table 62. Global Insomnia Medication Sales Forecast by Type (2021-2026) & (K Pcs)
Table 63. Global Insomnia Medication Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Insomnia Medication Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Insomnia Medication Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Insomnia Medication Sales Forecast by Application (2021-2026) & (K Pcs)
Table 67. Global Insomnia Medication Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Insomnia Medication Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Insomnia Medication Revenue Market Share Forecast by Application (2021-2026)
Table 70. Eisai Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 71. Eisai Insomnia Medication Product Offered
Table 72. Eisai Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 73. Eisai Main Business
Table 74. Eisai Latest Developments
Table 75. Merck Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 76. Merck Insomnia Medication Product Offered
Table 77. Merck Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 78. Merck Main Business
Table 79. Merck Latest Developments
Table 80. Pfizer Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Insomnia Medication Product Offered
Table 82. Pfizer Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Sanofi Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Insomnia Medication Product Offered
Table 87. Sanofi Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Takeda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Insomnia Medication Product Offered
Table 92. Takeda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Vanda Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 96. Vanda Pharmaceuticals Insomnia Medication Product Offered
Table 97. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 98. Vanda Pharmaceuticals Main Business
Table 99. Vanda Pharmaceuticals Latest Developments
Table 100. Astellas Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 101. Astellas Insomnia Medication Product Offered
Table 102. Astellas Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 103. Astellas Main Business
Table 104. Astellas Latest Developments
Table 105. Dainippon Sumitomo Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 106. Dainippon Sumitomo Insomnia Medication Product Offered
Table 107. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 108. Dainippon Sumitomo Main Business
Table 109. Dainippon Sumitomo Latest Developments
Table 110. ECR Pharmaceuticals (Valeant) Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 111. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offered
Table 112. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 113. ECR Pharmaceuticals (Valeant) Main Business
Table 114. ECR Pharmaceuticals (Valeant) Latest Developments
Table 115. Flynn Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 116. Flynn Pharma Insomnia Medication Product Offered
Table 117. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 118. Flynn Pharma Main Business
Table 119. Flynn Pharma Latest Developments
Table 120. Johnson & Johnson Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 121. Johnson & Johnson Insomnia Medication Product Offered
Table 122. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 123. Johnson & Johnson Main Business
Table 124. Johnson & Johnson Latest Developments
Table 125. Meda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 126. Meda Insomnia Medication Product Offered
Table 127. Meda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 128. Meda Main Business
Table 129. Meda Latest Developments
Table 130. Somnus Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 131. Somnus Therapeutics Insomnia Medication Product Offered
Table 132. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 133. Somnus Therapeutics Main Business
Table 134. Somnus Therapeutics Latest Developments
Table 135. Purdue Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 136. Purdue Pharma Insomnia Medication Product Offered
Table 137. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 138. Purdue Pharma Main Business
Table 139. Purdue Pharma Latest Developments
Table 140. Neurim Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 141. Neurim Insomnia Medication Product Offered
Table 142. Neurim Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 143. Neurim Main Business
Table 144. Neurim Latest Developments
Table 145. Minerva Neurosciences Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 146. Minerva Neurosciences Insomnia Medication Product Offered
Table 147. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 148. Minerva Neurosciences Main Business
Table 149. Minerva Neurosciences Latest Developments
Table 150. Pernix Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 151. Pernix Therapeutics Insomnia Medication Product Offered
Table 152. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 153. Pernix Therapeutics Main Business
Table 154. Pernix Therapeutics Latest Developments
Table 155. SkyePharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 156. SkyePharma Insomnia Medication Product Offered
Table 157. SkyePharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 158. SkyePharma Main Business
Table 159. SkyePharma Latest Developments
Table 160. Paratek Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 161. Paratek Pharmaceuticals Insomnia Medication Product Offered
Table 162. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 163. Paratek Pharmaceuticals Main Business
Table 164. Paratek Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Insomnia Medication
Figure 2. Insomnia Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insomnia Medication Sales Growth Rate 2016-2026 (K Pcs)
Figure 7. Global Insomnia Medication Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Insomnia Medication Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Nonbenzodiazepine Receptor Agonists
Figure 10. Product Picture of Benzodiazepine Receptor Agonists
Figure 11. Product Picture of The Selective Melatonin Receptor Agonist Ramelteon
Figure 12. Product Picture of Sedating Antidepressants
Figure 13. Global Insomnia Medication Sales Market Share by Type in 2020
Figure 14. Global Insomnia Medication Revenue Market Share by Type (2016-2021)
Figure 15. Insomnia Medication Consumed in Adults
Figure 16. Global Insomnia Medication Market: Adults (2016-2021) & (K Pcs)
Figure 17. Insomnia Medication Consumed in Kids
Figure 18. Global Insomnia Medication Market: Kids (2016-2021) & (K Pcs)
Figure 19. Global Insomnia Medication Sales Market Share by Application (2016-2021)
Figure 20. Global Insomnia Medication Revenue Market Share by Application in 2020
Figure 21. Global Insomnia Medication Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Insomnia Medication Revenue Market Share by Company in 2020
Figure 23. Global Insomnia Medication Sales Market Share by Regions (2016-2021)
Figure 24. Global Insomnia Medication Revenue Market Share by Region in 2020
Figure 25. Americas Insomnia Medication Sales 2016-2021 (K Pcs)
Figure 26. Americas Insomnia Medication Revenue 2016-2021 ($ Millions)
Figure 27. APAC Insomnia Medication Sales 2016-2021 (K Pcs)
Figure 28. APAC Insomnia Medication Revenue 2016-2021 ($ Millions)
Figure 29. Europe Insomnia Medication Sales 2016-2021 (K Pcs)
Figure 30. Europe Insomnia Medication Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Insomnia Medication Sales 2016-2021 (K Pcs)
Figure 32. Middle East & Africa Insomnia Medication Revenue 2016-2021 ($ Millions)
Figure 33. Americas Insomnia Medication Sales Market Share by Country in 2020
Figure 34. Americas Insomnia Medication Revenue Market Share by Country in 2020
Figure 35. Americas Insomnia Medication Sales Market Share by Type in 2020
Figure 36. Americas Insomnia Medication Sales Market Share by Application in 2020
Figure 37. United States Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Insomnia Medication Sales Market Share by Region in 2020
Figure 42. APAC Insomnia Medication Revenue Market Share by Regions in 2020
Figure 43. APAC Insomnia Medication Sales Market Share by Type in 2020
Figure 44. APAC Insomnia Medication Sales Market Share by Application in 2020
Figure 45. China Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Insomnia Medication Sales Market Share by Country in 2020
Figure 52. Europe Insomnia Medication Revenue Market Share by Country in 2020
Figure 53. Europe Insomnia Medication Sales Market Share by Type in 2020
Figure 54. Europe Insomnia Medication Sales Market Share by Application in 2020
Figure 55. Germany Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Insomnia Medication Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Insomnia Medication Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Insomnia Medication Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Insomnia Medication Sales Market Share by Application in 2020
Figure 64. Egypt Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Insomnia Medication Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
【免責事項】
https://www.globalresearch.jp/disclaimer